ArticleFrontiers in neurology
Angiographic collateral status predicts functional outcome and early neurological deterioration in large-vessel occlusion stroke treated with endovascular therapy.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite successful recanalization with endovascular treatment (EVT) for acute ischemic stroke (AIS), many patients experience poor outcomes. While collateral circulation is a known prognostic factor, its dynamic assessment via digital subtraction angiography (DSA) and its relationship to outcomes post-EVT require further investigation. Methods: This single-center retrospective study analyzed 185 consecutive AIS patients with large vessel occlusion treated with EVT. Collateral status was graded on pre-treatment DSA using the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) scale and categorized as poor, fair, or good. The primary outcome was functional independence (modified Rankin Scale [mRS] score 0-2) at 90 days. Secondary outcomes included early neurological deterioration (END) within 7 days and 90-day mortality. Results: Patients with good collaterals had significantly higher rates of functional independence (66.1%) compared to those with fair (45.9%) and poor collaterals (13.2%). Conversely, the incidences of END (1.8% vs. 8.2% vs. 23.5%) and 90-day mortality (1.8% vs. 11.5% vs. 27.9%) were progressively higher in the good, fair, and poor collateral groups, respectively. Multivariable logistic regression confirmed that a higher collateral score was an independent predictor of good functional outcome and was independently associated with a lower risk of END and mortality. Conclusion: DSA-assessed collateral status is a strong independent predictor of 90-day functional outcome, END, and mortality in AIS patients following EVT. Robust pretreatment collaterals are associated with markedly improved recovery and survival, highlighting the critical prognostic value of collateral assessment in guiding treatment and patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.